Binance Coin price moved sideways on Monday as traders waited for the upcoming Fermi hard fork.Binance Coin price moved sideways on Monday as traders waited for the upcoming Fermi hard fork.

Binance Coin price forms a bearish pennant ahead of the Fermi hard fork

Binance Coin price moved sideways on Monday as traders waited for the upcoming Fermi hard fork.

Summary
  • Binance Coin price remained unchanged at $900 on Monday.
  • The BSC Chain will launch the Fermi hard fork this week.
  • Technical analysis suggests that the token may retreat soon.

Binance Coin (BNB) token was stuck at the psychological point of $900, where it has been in the past few days. This price is much lower than the all-time high of $1,375. 

BNB price has wavered despite having some major catalysts. The first key catalyst will happen on January 14 when it will activate the Fermi hard fork. This hard fork aims to improve its performance, with its block time falling to 0.45 seconds. 

Fermi will also introduce faster finality as its throughput increases and its smoother app performance. It is the fourth hard fork in the BSC Chain after Maxwell, Pascal, and Lorentz.

The other three upgrades helped to lower its block times as its usage jumped. This higher speed enabled it to compete more effectively with top competitors such as Solana and Ethereum. 

The Fermi hard fork comes as BSC network growth continues. For example, data compiled by Nansen indicate that active addresses increased by 0.7% to 41.1 million, while transactions rose to 403 million over the last 30 days. 

The network is averaging 4.2 million daily active users. It also processed over $43.9 billion in DEX volume in the last 30 days, a trend that will continue to grow in the near term. 

Binance Coin will also execute a big token burn in the coming weeks. It will burn 1.37 million tokens worth over $1.276 billion as part of the quarterly auto-burn. Additionally, Grayscale is expected to file for a spot BNB ETF soon, joining VanEck. 

Binance Coin price technical analysis 

Binance Coin

The daily chart shows that the BNB price has crashed in the past few months. It has crashed from a high of $1,375 in October to the current $900.

The coin remains between the 50% and 61.8% Fibonacci Retracement levels. It has moved above the 50-day and 200-day moving averages, which is a bullish sign. 

However, it has formed a rising wedge pattern, characterized by two converging trendlines. This wedge is also part of the bearish pennant pattern. 

Therefore, the coin will likely have a bearish breakout, with the next target at the support level of $788, its lowest point on Nov. 21. This target is ~12% below the current level.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23